Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Safety, Pharmacokinetic, and Pharmacodynamic Study of APS001F With Flucytosine and Maltose for the Treatment of Advanced and/or Metastatic Solid Tumors

NCT01562626 is registered in ClinicalTrials.gov with Anaeropharma Science, Inc. as lead sponsor.

NCT NCT01562626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01562626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Safety, Pharmacokinetic, and Pharmacodynamic Study of APS001F With Flucytosine and Maltose for the Treatment of Advanced and/or Metastatic Solid Tumors
Lead sponsor
Anaeropharma Science, Inc.
Phase
Phase 1/2
Overall status
Suspended
Start date
September 30, 2012
Completion date
May 31, 2021
Enrollment
75 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neoplasms, tumors